{"version":"1.0","provider_name":"Malaysian Tribune","provider_url":"https:\/\/malaysiantribune.com","author_name":"admin","author_url":"https:\/\/malaysiantribune.com\/author\/admin\/","title":"Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates - Malaysian Tribune","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"4nxQWVWxBn\"><a href=\"https:\/\/malaysiantribune.com\/junshi-biosciences-announces-2021-interim-financial-results-and-provides-corporate-updates\/\">Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/malaysiantribune.com\/junshi-biosciences-announces-2021-interim-financial-results-and-provides-corporate-updates\/embed\/#?secret=4nxQWVWxBn\" width=\"600\" height=\"338\" title=\"&#8220;Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates&#8221; &#8212; Malaysian Tribune\" data-secret=\"4nxQWVWxBn\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) \u2014 Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the six months ended June 30, 2021 and provided corporate updates. First Half 2021 Financial Highlights Total revenue reached RMB 2,114 [\u2026]","thumbnail_url":"https:\/\/ci5.googleusercontent.com\/proxy\/H7N8ZnU32oc-PiRs-Kc4mHzBjZnDzmhHil-aPL3iHkCqvdHkejgQE8BrLKiZG66r8ukK2H0Fcd99p3rSemYBOnN19D8RmaKIQHn1biN7Zc_8tprlgWT_9RwzwsB3E66q=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNzUyMCM0MzgxNzc5IzIxOTUzNzU="}